Abiopharma

News list

Rolke James 🟢 acquired 532.8K shares of REVELATION BIOSCIENCES, INC. (REVB) at $0.90 Transaction Date: Jan 08, 2026 | Filing ID: 010648

Full text

News bot Jan. 12, 2026, 10:26 p.m.
🔍 Rolke James (Executive)

Company: REVELATION BIOSCIENCES, INC. (REVB)

Report Date: 2026-01-08
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 532,829
- Total shares held: 400,660
Detailed Transactions and Holdings:
- Acquired 532,829 shares of Common Stock at $0.9 per share (Direct)
  Date: 2026-01-08 | Code: A | equity_swap_involved: false | shares_owned_after: 933,489.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | shares_owned_after: 400,660.00
Footnotes:
- F1: Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.